Search research articles
Contact Us
Filters
Showing results (141-150 of 460) with videos related to
Page
of 46
Sort By:
International Journal of Cancer
|
April 12, 2002
Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells
Rinat Eshel, Alexandra Zanin, Dina Kapon, et al.
Journal of Proteomics
|
February 9, 2010
Protein biomarker discovery for head and neck cancer
Tieneke B M Schaaij-Visser, Ruud H Brakenhoff, C René Leemans, et al.
BMC Genomics
|
February 19, 2010
Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility
Koen Bossers, Bauke Ylstra, Ruud H Brakenhoff, et al.
Head & Neck
|
October 22, 2025
Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross-Species Multi-Cohort Bioinformatic Study
Rui Han, Jos B Poell, Cristina Conde-Lopez, et al.
Cell
|
September 12, 1986
Major transcript of the frameshifted coxII gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA
R Benne, J Van den Burg, J P Brakenhoff, et al.
Oral Oncology
|
April 13, 2013
Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines
Remco Nagel, Sanne R Martens-de Kemp, Marijke Buijze, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
Residues 77-95 of the human interleuken-6 protein are responsible for receptor binding and residues 41-56 for signal transduction
M Ehlers, J Grötzinger, F D de Hon, et al.
Veterinary Surgery : VS
|
August 17, 2006
The prevalence of laryngeal disease in a large population of competition draft horses
Jeffrey E Brakenhoff, Susan J Holcombe, Joe G Hauptman, et al.
Alimentary Pharmacology & Therapeutics
|
February 22, 2021
Editorial: HBV cure-the quest for biomarkers to predict off-treatment sustained response. Authors' reply
Sylvia M Brakenhoff, Robert A de Man, Robert J de Knegt, et al.
Cell Biophysics
|
January 1, 1994
Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48
M Gerretsen, G W Visser, R H Brakenhoff, et al.
Page
of 46
Search research articles
Search
Showing results (141-150 of 460) with videos related to
Sort By:
Page
of 46
International Journal of Cancer
|
April 12, 2002
Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells
Rinat Eshel, Alexandra Zanin, Dina Kapon, et al.
Journal of Proteomics
|
February 9, 2010
Protein biomarker discovery for head and neck cancer
Tieneke B M Schaaij-Visser, Ruud H Brakenhoff, C René Leemans, et al.
BMC Genomics
|
February 19, 2010
Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility
Koen Bossers, Bauke Ylstra, Ruud H Brakenhoff, et al.
Head & Neck
|
October 22, 2025
Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross-Species Multi-Cohort Bioinformatic Study
Rui Han, Jos B Poell, Cristina Conde-Lopez, et al.
Cell
|
September 12, 1986
Major transcript of the frameshifted coxII gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA
R Benne, J Van den Burg, J P Brakenhoff, et al.
Oral Oncology
|
April 13, 2013
Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines
Remco Nagel, Sanne R Martens-de Kemp, Marijke Buijze, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
Residues 77-95 of the human interleuken-6 protein are responsible for receptor binding and residues 41-56 for signal transduction
M Ehlers, J Grötzinger, F D de Hon, et al.
Veterinary Surgery : VS
|
August 17, 2006
The prevalence of laryngeal disease in a large population of competition draft horses
Jeffrey E Brakenhoff, Susan J Holcombe, Joe G Hauptman, et al.
Alimentary Pharmacology & Therapeutics
|
February 22, 2021
Editorial: HBV cure-the quest for biomarkers to predict off-treatment sustained response. Authors' reply
Sylvia M Brakenhoff, Robert A de Man, Robert J de Knegt, et al.
Cell Biophysics
|
January 1, 1994
Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48
M Gerretsen, G W Visser, R H Brakenhoff, et al.
Page
of 46